Donna S. Grisham LADC

Recommended Articles

• Genetic Markers for Predicting Lupus Susceptibility

  Autoimmune diseases have plagued millions of people from different parts of the world. These disorders have unknown etiologies and have no cure to this day. Many patients diagnosed with some kind of autoimmune disease have mustered the courage and determined the pace to coexist with their illness...

• This Naval Officer Doesn't Let Multiple Sclerosis Stop Him

  The recent 2017 international Invictus Games was a star-studded event in Toronto, Canada. Invictus, fashioned after the American Warrior Games, is also for wounded members of the military, even veterans. Events include wheelchair basketball, an indoor rowing event, golf and volleyball, to name just...

• Diagnosing Epilepsy: What You Need to Know

  Sometimes, it can be difficult to know if an individual is having a bout of seizure. It is also not easy for physicians to make a diagnosis on what type of epilepsy or seizure a person has since there are various disorders that can be confused with epilepsy.The very first step, and probably the most...

• Obese Children Can Reduce Their Risk for Heart Disease

  In a new study, researchers analyzed data from four different studies to see if childhood obesity results in an increased risk of heart disease and other health problems. Results of the study, published in The New England Journal of Medicine, showed that obese children who cut down weight and reach...

• What is Low T?

  Low T, or low testosterone, refers to the reduced levels of the male hormone, testosterone, in the body. This condition is becoming increasingly common among males. Testosterone contributes to:...

• Does the Immune System Play a Role in Parkinson's?

  About 60,000 Americans are diagnosed with Parkinson's disease every year, with ten million people around the world suffering from it (http://www.pdf.org/parkinson_statistics). And unfortunately, there is no known cure yet. On the other hand, there are treatment plans that patients can follow to...